Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hazel M Dockrell

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Infection and Immunity|May 16, 2007
Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccinationMay Young Lin, Annemieke Geluk, Steven G Smith, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adultsGillian F Black, Rosemary E Weir, Steven D Chaguluka, et al.
Frontiers in Immunology|May 1, 2018
A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household ContactsFergal J Duffy, Ethan Thompson, Katrina Downing, et al.
Frontiers in Immunology|March 15, 2021
Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB DiseaseHygon Mutavhatsindi, Gian D van der Spuy, Stephanus T Malherbe, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
The Journal of Infection|June 18, 2016
Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB diseaseDolapo O Awoniyi, Andrea Teuchert, Jayne S Sutherland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2020
Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in TuberculosisClare Eckold, Vinod Kumar, January Weiner, et al.
Bulletin of the World Health Organization|November 21, 2018
Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South AfricaDaniel Grint, Bachti Alisjhabana, Cesar Ugarte-Gil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2021
Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim ResultsJayne S Sutherland, Gian van der Spuy, Awa Gindeh, et al.
Frontiers in Immunology|April 11, 2019
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease OutcomeFergal J Duffy, January Weiner, Scott Hansen, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Infection and Immunity|May 16, 2007
Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccinationMay Young Lin, Annemieke Geluk, Steven G Smith, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adultsGillian F Black, Rosemary E Weir, Steven D Chaguluka, et al.
Frontiers in Immunology|May 1, 2018
A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household ContactsFergal J Duffy, Ethan Thompson, Katrina Downing, et al.
Frontiers in Immunology|March 15, 2021
Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB DiseaseHygon Mutavhatsindi, Gian D van der Spuy, Stephanus T Malherbe, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosyJohn S Spencer, Hee Jin Kim, William H Wheat, et al.
The Journal of Infection|June 18, 2016
Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB diseaseDolapo O Awoniyi, Andrea Teuchert, Jayne S Sutherland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2020
Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in TuberculosisClare Eckold, Vinod Kumar, January Weiner, et al.
Bulletin of the World Health Organization|November 21, 2018
Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South AfricaDaniel Grint, Bachti Alisjhabana, Cesar Ugarte-Gil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2021
Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim ResultsJayne S Sutherland, Gian van der Spuy, Awa Gindeh, et al.
Frontiers in Immunology|April 11, 2019
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease OutcomeFergal J Duffy, January Weiner, Scott Hansen, et al.
Pageof 15